Ad
related to: moderna vaccine
Search results
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
CNN.com· 7 hours agoThe US Food and Drug Administration announced Friday that it had advised the makers of the Covid-19 ...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 12 hours agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 3 days agoRepresentatives from Moderna, Pfizer-BioNtech, and Novavax presented data about the protection...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 17 hours agoFurther, Moderna confirmed it's in discussions with the U.S. government to move forward with its...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
Morningstar· 15 hours agoManufacturing is underway and doses of Moderna's Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval CAMBRIDGE, MA / ACCESSWIRE ...
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 6 hours agoTwo other companies – Pfizer and Moderna – also manufacture RSV vaccines approved for adults 60 and...
Moderna director Noubar Afeyan sells over $2.2m in company stock By Investing.com
Investing.com· 7 hours agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has recently sold a substantial number of shares...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 8 hours agoThe shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for...
Moderna's MMA candidate nabs spot in FDA pilot for rare disease drugs
FierceBiotech· 20 hours agoModerna’s methylmalonic acidemia candidate, mRNA-3705, will be developed under the FDA’s START pilot...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 4 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...